MuscleHormonesAnti-AgingSubcutaneous

Tesamorelin / Ipamorelin Blend

2X

Typical Dose

100–300 mcg

Frequency

Daily

Half-Life

~30 min (Tes) + ~2 hrs (Ipa)

Research-use dosing; specific study population not established.

Tesamorelin / Ipamorelin Blend Overview

Mechanism of Action

Combines Tesamorelin (GHRH analog) with Ipamorelin (ghrelin mimetic) for synergistic GH release through dual-pathway stimulation.

Half-Life

~30 min (Tes) + ~2 hrs (Ipa)

Timing

Before bed on empty stomach

Common Stacks

  • CJC-1295
  • GHRP-6
  • Sermorelin

Tesamorelin / Ipamorelin Blend Dosing Protocol

Standard

100-300 mcg combined, daily

Tesamorelin / Ipamorelin Blend Expected Timeline

No timeline data available.

Tesamorelin / Ipamorelin Blend Side Effects

Water retention

Tingling

Increased hunger

Tesamorelin / Ipamorelin Blend Research Studies

No studies referenced.

Tesamorelin / Ipamorelin Blend FAQ

Why combine Tesamorelin and Ipamorelin?

Dual-pathway GH stimulation produces more robust and sustained GH release.

Related Protocols